Physician profile
Jeffrey Halley
NPI 1003807025
$1,395.70
in general payments reported to CMS, 2019-2025
17 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $162 · 2021: $30.95 · 2022: $245 · 2023: $174 · 2024: $311 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $265.54 | 2019-2025 | |
| Medtronic, INC. | $254.75 | 2022-2024 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $153.90 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $140.98 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $113.02 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $99.44 | 2020-2023 | Brilinta, Farxiga |
| Amgen INC. | $62.16 | 2019-2025 | Repatha |
| Pfizer INC. | $52.29 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.59 | 2020-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.85 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $44.29 | 2022-2024 | Verquvo |
| Abbott Laboratories | $25.01 | 2024 | Cardiomems |
| Novo Nordisk INC | $20.00 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $17.92 | 2025 | |
| Axsome Therapeutics, INC. | $17.35 | 2025 | Sunosi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $16.79 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Halley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.